A phase 1 trial of the HDAC inhibitor AR-42 in patients...

  • Main
  • 2017 / 03
  • A phase 1 trial of the HDAC inhibitor AR-42 in patients...
Leukemia and Lymphoma 2017 / 03

A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas

Sborov, Douglas W., Canella, Alessandro, Hade, Erinn M., Mo, Xiaokui, Khountham, Soun, Wang, Jiang, Ni, Wenjun, Poi, Ming, Coss, Christopher, Liu, Zhongfa, Phelps, Mitch A., Mortazavi, Amir, Andritsos
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2017.1298751
Date:
March, 2017
File:
PDF, 1.08 MB
english, 2017
Conversion to is in progress
Conversion to is failed